We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 138% below its sector, cheaper than its peers on earnings.
TFBS Bioscience Inc. functions as a contract research organization (CRO), specializing in offering biological analysis and testing services throughout Taiwan. The company plays a crucial role in supporting advanced medical innovations by fabricating viral vectors, which are essential for cell and gene therapy products. Furthermore, TFBS Bioscience conducts comprehensive biosafety and final product release evaluations for a diverse range of biopharmaceutical items, including cell and gene therapies, vaccines, and other biologics. Established in 2016, the firm's main operational base is located in New Taipei City, Taiwan.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 6939.TWO and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
